-Medical Internist, Stamford Hospital, 2003-present 

-Deputy Commissioner for Medical and Scientific Affairs, FDA, 2005-2007 

-Resident Fellow, American Enterprise Institute, 2004-2005  

-Senior Adviser to the Administrator, CMS, 2004 

-Director of Medical Policy Development, FDA, 2004   

-Senior Adviser for Medical Technology to the FDA Commissioner, 2003-2004 

-Columnist, Forbes.com, 2007-present

-Author, Forbes-Gottlieb Medical Technology Report, 2004-2005

-Staff Writer, British Medical Journal, 1997-2005

-Author, Gilder Biotech Report, 2000-2002

-Senior Editor, Pulse, Journal of the American Medical Association, 1996-2001

-Health Care Analyst, Alex Brown & Sons (investment bank), 1994-1995

Education
M.D., Mount Sinai School of Medicine
B.A., economics, Wesleyan University

Articles and Short Publications

Michelle Obama Is Right about Avoiding the ER Herbal Legends Pharmaceutical Promotion and First Amendment Rights

[List All]

Events

Off-Label Uses of Approved Drugs: Medicine, Law, and Policy Oncology Drug Development: Rethinking FDA Oversight What Should Congress Do about Generic or Follow-On Biologic Drugs?

[List All]

Speaking Engagements

Access to Information in the People's Republic of China Safety of Chinese Imports Achieving Drug Access and Affordability without Trading on Future Innovation

[List All]